Differences

This shows you the differences between two versions of the page.

--- eliana_castillo [2022/04/22 20:03]
liam
+++ eliana_castillo [2022/04/22 20:34] (current)
liam [Public Health Agency of Canada]
@@ Line 6: / Line 6: @@
 ===== Career and Affiliations =====
+==== University of British Columbia ====
+Castillo completed a fellowship as a clinical assistant professor at the [[University of British Columbia]] (UBC).((//Live Q&A: COVID-19 vaccine.// (2021, September 29). Calgary Health Foundation. https://www.calgaryhealthfoundation.ca/events/live-qa-covid-19-vaccine/))
 ==== University of Calgary ====
-Castillo is a clinical associate professor in the Department of Microbiology Immunology and Infectious Diseases at the [[University of Calgary]].(())
+Castillo is a clinical associate professor in the Department of Microbiology Immunology and Infectious Diseases at the [[University of Calgary]].((//Eliana Castillo.// (2020, July 29). Cumming School of Medicine. https://archive.ph/m1R96))
 ==== Public Health Agency of Canada ====
 Castillo is a liaison representative for the [[Society of Obstetrics and Gyneacologists]] on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
+==== Canadian Immunization Research Network ====
+Castillo is a co-investigator for the Social Sciences and Humanities Network (SSHN) at the [[Canadian Immunization Research Network]].((//Social Sciences and Humanities Network (SSHN).// (2014, October 22). CIRN | Canadian Immunization Research Network. https://cirnetwork.ca/network/social-sciences-and-humanities-network/))
+===== Presentations =====
+Castillo was a workshop facilitator for a presentation on [[pertussis vaccines]] at the 2016 [[Canadian Immunization Conference]], sponsored by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Innovative Medicines Canada]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[Public Health Ontario]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Seqirus]], [[Vaccines 411]] and [[pharmaceutical_companies:Valneva]].((//CIC 2016 Final Program.// Canadian Immunization Conference. Retrieved April 22, 2022, from https://web.archive.org/web/20220420010352/https://www.cpha.ca/sites/default/files/uploads/conferences/2021/cic16-final-program-en.pdf))